Several articles featured in a recent issue of the highly respected publication the Medical Letter on Drugs and Therapeutics highlight themes across drug development that are relevant within the broad antineoplastic arena. The topics range from appropriate control arms in randomized clinical trials to sponsorship of trials to the rationale for developing novel agents when suitable, cost-effective biosimilar and generic products are available.
The atypical antipsychotic cariprazine, which is approved for schizophrenia and bipolar disorder, is also effective as an adjunct treatment for resistant depression, results of a new phase 3 trial show.
Henderson County (May 22, 2022) - Thanks to a generous grant from VayaHealth in summer 2021, The Free Clinics added six psychotropic medications to its Community Pharmacy formulary that have historically been out of reach for its patients due to pricing constraints.